Home > D. Systemic pathology > Toxics and drugs > Therapeutics > Targeted therapy > anti-C5 drugs

anti-C5 drugs

Monday 2 January 2012

Types

- eculizumab (INN and USAN, trade name Soliris)

See also

- targeted therapy